Posts

Showing posts from June, 2021

Corruption in Pharmaceuticals – International Perspective 10 – Blog Post #504 by Asrar Qureshi

Image
Corruption in Pharmaceuticals – International Perspective 10 – Blog Post #504 by Asrar Qureshi Dear Colleagues!  This is Pharma Veterans Blog Post #504. Pharma Veterans welcomes sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Continued from Previous…… This series is based on a report compiled by Jilian Clare Cohen1, Monique Mrazek2, and Loraine Hawkins3 for World Bank. Six decision points were identified where corruption could infiltrate. The first was manufacturing, second was marketing authorization, third was selection, fourth was procurement, fifth was distribution, sixth was drug prescribing and dispensing. Selected Strategies to Mitigate Corruption in Pharmaceutical Systems The report goes on to make recommendations for certain strategies to mitigate the risk of corruption. It is more

Corruption in Pharmaceuticals – International Perspective 9 – Blog Post #503 by Asrar Qureshi

Image
Corruption in Pharmaceuticals – International Perspective 9 – Blog Post #503 by Asrar Qureshi Dear Colleagues!  This is Pharma Veterans Blog Post #503. Pharma Veterans welcomes sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Continued from Previous…… This series is based on a report compiled by Jilian Clare Cohen1, Monique Mrazek2, and Loraine Hawkins3 for the World Bank. Six decision points were identified where corruption could infiltrate. The first was manufacturing, second was marketing authorization, third was selection, fourth was procurement, fifth was distribution, sixth is discussed below. Decision Point Six: Drug Prescribing and Dispensing [Quote] Drug prescribing and dispensing involves the participation of physicians, pharmacists, nurses, and other health-care providers who diagn

Corruption in Pharmaceuticals – International Perspective 8 – Blog Post #502 by Asrar Qureshi

Image
Corruption in Pharmaceuticals – International Perspective 8 – Blog Post #502 by Asrar Qureshi Dear Colleagues!  This is Pharma Veterans Blog Post #502. Pharma Veterans welcomes sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Continued from Previous…… This series is based on a report compiled by Jilian Clare Cohen1, Monique Mrazek2, and Loraine Hawkins3 for World Bank. Six decision points were identified where corruption could infiltrate. The first was manufacturing, second was marketing authorization, third was selection, fourth was procurement, fifth is discussed below. Decision Point Five: Distribution [Quote] Whether it is a government agency or a private company that is contracted out by the government to distribute drugs, the system needs to ensure the timely and safe delivery of approp

Corruption in Pharmaceuticals – International Perspective 7 – Blog Post #501 by Asrar Qureshi

Image
Corruption in Pharmaceuticals – International Perspective 7 – Blog Post #501 by Asrar Qureshi Dear Colleagues!  This is Pharma Veterans Blog Post #501. Pharma Veterans welcomes sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Continued from Previous…… This series is based on a report compiled by Jilian Clare Cohen1, Monique Mrazek2, and Loraine Hawkins3 for World Bank. Six decision points were identified where corruption could infiltrate. The first was manufacturing, second was marketing authorization, third was selection, fourth is discussed below. Decision Point Four: Procurement [Quote] Procurement is the principal interface between the public system and drug suppliers, and its goal is to acquire the right quantity of drugs in the most cost-effective manner. Government functions in this de

Pharma Veterans' 500th Blog – Blog Post #500 by Asrar Qureshi

Image
Pharma Veterans' 500 th Blog – Blog Post #500 by Asrar Qureshi Dear Colleagues!  This is Pharma Veterans Blog Post #500. Pharma Veterans welcomes sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. DEAR PHARMA VETERANS, COLLEAGUES AND READERS!  IT PLEASES ME AND HUMBLES ME TO ANNOUNCE THE PUBLISHING OF THE 500TH BLOG TODAY. I planned to write a blog in 2017. I had a short stint earlier with blog writing in 2012 -13. I wrote under the title of ‘Management Matters’ and the blog was published on WordPress free site. I wrote about twenty blogs, but the frequency was not consistent. The main topic was ‘Management’ but the aspects were too varied. This was not an enviable background. In 2016, I joined the Recognized Expert course with Dorie Clark and became a part of the amazing, versatile, and h

Corruption in Pharmaceuticals – International Perspective 6 – Blog Post #499 by Asrar Qureshi

Image
Corruption in Pharmaceuticals – International Perspective 6 – Blog Post #499 by Asrar Qureshi Dear Colleagues!  This is Pharma Veterans Blog Post #499. Pharma Veterans welcomes sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Continued from Previous…… This series is based on a report compiled by Jilian Clare Cohen1, Monique Mrazek2, and Loraine Hawkins3 for World Bank. Six decision points were identified where corruption could infiltrate. The first was manufacturing, second was marketing authorization, third is discussed below. Decision Point Three: Selection Pakistan allocates a fair amount of budget every year for public healthcare. It covers procurement of medicines, medical disposables, medical equipment and running of public healthcare infrastructure. It is a huge structure with billions

Corruption in Pharmaceuticals – International Perspective 5 – Blog Post #498 by Asrar Qureshi

Image
Corruption in Pharmaceuticals – International Perspective 5 – Blog Post #498 by Asrar Qureshi Dear Colleagues!  This is Pharma Veterans Blog Post #498. Pharma Veterans welcomes sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Continued from Previous…… This series is based on a report compiled by Jilian Clare Cohen1, Monique Mrazek2, and Loraine Hawkins3 for World Bank. Six decision points were identified where corruption could infiltrate. The first was manufacturing which was taken up in the last blog. Second is discussed below. Decision Point Two: Registration and Market Authorization 1950s saw the great tragedy of a large number of limbless children born to women who were taking the drug, thalidomide. The drug was introduced as a sedative and became a popular prescription rapidly. Soon, re

Corruption in Pharmaceuticals – International Perspective 4 – Blog Post #497 by Asrar Qureshi

Image
Corruption in Pharmaceuticals – International Perspective 4 – Blog Post #497 by Asrar Qureshi Dear Colleagues!  This is Pharma Veterans Blog Post #497. Pharma Veterans welcomes sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Continued from Previous…… This series is based on a report compiled by Jilian Clare Cohen1, Monique Mrazek2, and Loraine Hawkins3 for World Bank. Corruption is spread easily across many areas if the regulatory systems are inefficient and/or incompetent. Pharmaceutical business is among the most regulated businesses and is therefore subject to the same phenomena. Not long ago, Pharma was rather loosely regulated. However, there have significant changes in the last three decades or so. The regulators have identified areas where corruption may occur and have installed regul

Corruption in Pharmaceuticals – International Perspective 3 – Blog Post #496 by Asrar Qureshi

Image
Corruption in Pharmaceuticals – International Perspective 3 – Blog Post #496 by Asrar Qureshi Dear Colleagues!  This is Pharma Veterans Blog Post #496. Pharma Veterans welcomes sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Continued from Previous…… This series is based on report compiled by Jilian Clare Cohen 1 , Monique Mrazek 2 , and Loraine Hawkins 3 for World Bank. Governments have the responsibility to install reliable institutional policies, processes, and administrative structure to ensure the outcome of public welfare. Both the main arms of healthcare system vis-à-vis pharmaceuticals need government attention. First is the manufacture/production/quality control of medicines being manufactured by the Pharma companies. Second is the system of medicines procurement by the government

Corruption in Pharmaceuticals – International Perspective 2 – Blog Post #495 by Asrar Qureshi

Corruption in Pharmaceuticals – International Perspective 2 – Blog Post #495 by Asrar Qureshi Dear Colleagues!  This is Pharma Veterans Blog Post #495. Pharma Veterans welcomes sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Continued from Previous…… This series is based on report compiled by Jilian Clare Cohen 1 , Monique Mrazek 2 , and Loraine Hawkins 3 for World Bank. Corruption is a factor which has wide ranging implications. Quality of a product has direct bearing on the outcome of therapy at the minimum, and serious health hazards, including death at the maximum. In all countries, quality measures and regulations are in place, thanks mainly to WHO which has provided guidance and arranged trainings at its own cost. The implementation of regulations is, however, responsibility of count

Corruption in Pharmaceuticals – International Perspective 1 – Blog Post #494 by Asrar Qureshi

Image
Corruption in Pharmaceuticals – International Perspective 1 – Blog Post #494 by Asrar Qureshi Dear Colleagues!  This is Pharma Veterans Blog Post #493. Pharma Veterans welcomes sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Jilian Clare Cohen Loraine Hawkins Monique Mrazek Pharmaceutical Industry is as much prone to corruption as any other industry. Businesses are for profit and they strive to maximize volumes and profits. During this process, possibility of getting boost through corrupt practices keeps coming along. Pharmaceutical industry is a highly regulated industry worldwide but is not free from malpractices. Key areas for corruption are those where key decisions are taken. These include, but may not be limited to, manufacturing, registration, selection, procurement, distribution, pre

Keeping Sane in a Noisy World 3 – Blog Post #493 by Asrar Qureshi

Image
Keeping Sane in a Noisy World 3 – Blog Post #493 by Asrar Qureshi Dear Colleagues!  This is Pharma Veterans Blog Post #493. Pharma Veterans welcomes sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Continued from Previous…… In this last part, we look at the suggestions about our topic, ‘Keeping Sane in a Noisy World’. It is imperative that we keep sane, it is clear that the world is becoming noisier by the day, and it is understood that the solutions are neither simple nor straightforward. We also know that we can control our own behaviors but cannot control others. Our focus, therefore, will be on our own actions. Reduce Screen Time New phones have the provision to calculate and inform about the time spent on watching phone screen. Please go to settings and set up this feature. It will ke

Keeping Sane in a Noisy World 2 – Blog Post #492 by Asrar Qureshi

Image
Keeping Sane in a Noisy World 2 – Blog Post #492 by Asrar Qureshi Dear Colleagues!  This is Pharma Veterans Blog Post #492. Pharma Veterans welcomes sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Continued from Previous…… The sources of noise in the social media may be identified as follows. Abundance & Overflow The number of new messages, repeats, forwards, multiple forwards and copied content is overwhelming. There are fewer creators of content, while an enormous number keeps forwarding it or copy-pasting it. The addictive senders, which most of the users are, start sending messages early morning, and continue late in the night. We notice messages received at 2.00am and 3.00am. Then there may be a short break, and it starts again from 4.00am. The reason for so much abundance is that i